Literature DB >> 17548062

Attenuation of reperfusion injury by renal ischemic postconditioning: the role of NO.

Xiuheng Liu1, Hui Chen, Bingyan Zhan, Bianzhi Xing, Jiangqiao Zhou, Hengcheng Zhu, Zhiyuan Chen.   

Abstract

Ischemic postconditioning (Postcond) is defined as rapid intermittent interruptions of blood flow in the early phase of reperfusion and mechanically alters the hydrodynamics of reperfusion. Although Postcond has been demonstrated to attenuate ischemia/reperfusion (I/R) injury in the heart and brain, its roles to renal I/R injury remain to be defined. In the present study, we examined the role of Postcond in I/R injury in a right-nephrectomized rat model. Postcond prevents the renal dysfunction and cell apoptosis induced by I/R and increases nitric oxide (NO) release and renal NO synthase (endothelial, eNOS and inducible, iNOS) expression. In contrast, enhancement of endothelin-1 (ET-1) in the kidney after the reperfusion was markedly suppressed by Postcond. These findings indicate that Postcond can inhibit renal I/R injury. The protective effect of Postcond is closely related to the NO production following the increase in eNOS and iNOS expression and the suppressive effect of ET-1 overproduction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17548062     DOI: 10.1016/j.bbrc.2007.05.129

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  31 in total

Review 1.  Ischemic conditioning-induced endogenous brain protection: Applications pre-, per- or post-stroke.

Authors:  Yuechun Wang; Cesar Reis; Richard Applegate; Gary Stier; Robert Martin; John H Zhang
Journal:  Exp Neurol       Date:  2015-04-18       Impact factor: 5.330

2.  Ischemic postconditioning inhibits apoptosis of renal cells following reperfusion: a novel in vitro model.

Authors:  Xiaodong Weng; Min Wang; Hui Chen; Zhiyuan Chen; Xiuheng Liu
Journal:  Int Urol Nephrol       Date:  2015-05-05       Impact factor: 2.370

3.  Roles of MAPKAPK-2 and HSP27 in the reduction of renal ischemia-reperfusion injury by ischemic postconditioning in rats.

Authors:  Anzhou Xia; Yong Li; Na Li; Zhi Xue; Jieyun Xia; Tiantian Wei; Jing Cao
Journal:  Int Urol Nephrol       Date:  2014-06-14       Impact factor: 2.370

Review 4.  Adiponectin: mechanisms and new therapeutic approaches for restoring diabetic heart sensitivity to ischemic post-conditioning.

Authors:  Tingting Wang; Shanglong Yao; Zhengyuan Xia; Michael G Irwin
Journal:  Front Med       Date:  2013-07-20       Impact factor: 4.592

5.  Post-conditioning with gradually increased reperfusion provides better cardioprotection in rats.

Authors:  Guo-Ming Zhang; Yu Wang; Tian-de Li; Xiao-Yan Li; Shao-Ping Su; Yuan-Yuan Sun; Xiu-Hua Liu
Journal:  World J Emerg Med       Date:  2014

6.  Ischemic postconditioning confers cardioprotection and prevents reduction of Trx-1 in young mice, but not in middle-aged and old mice.

Authors:  Virginia Perez; Verónica D Annunzio; Tamara Mazo; Timoteo Marchini; Lourdes Caceres; Pablo Evelson; Ricardo J Gelpi
Journal:  Mol Cell Biochem       Date:  2016-03-01       Impact factor: 3.396

7.  Does gradual detorsion protect the ovary against ischemia-reperfusion injury in rats?

Authors:  Sezen Ozkisacik; Mesut Yazici; Harun Gursoy; Nil Culhaci
Journal:  Pediatr Surg Int       Date:  2014-02-12       Impact factor: 1.827

8.  Role of P2X7 purinoceptors in neuroprotective mechanism of ischemic postconditioning in mice.

Authors:  Chanpreet Singh Bindra; Amteshwar Singh Jaggi; Nirmal Singh
Journal:  Mol Cell Biochem       Date:  2014-02-04       Impact factor: 3.396

Review 9.  Remote ischemic preconditioning as treatment for non-ischemic gastrointestinal disorders: beyond ischemia-reperfusion injury.

Authors:  Carlos Rodrigo Camara-Lemarroy
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

10.  Immediate postconditioning during reperfusion attenuates intestinal injury.

Authors:  Ke-Xuan Liu; Yun-Sheng Li; Wen-Qi Huang; Shu-Qing Chen; Zhong-Xin Wang; Jia-Xin Liu; Zhengyuan Xia
Journal:  Intensive Care Med       Date:  2009-02-04       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.